{"schema_version":"secwatch.filing_event.v1","accession":"0001388658-25-000194","form_type":"8-K","ticker":"IRTC","cik":"0001388658","company_name":"iRhythm Holdings, Inc.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.866382+00:00","generated_at":"2026-05-17T22:13:52.701934+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"iRhythm Q2 revenue up 26.1% to $186.7M; net loss narrows to $14.2M; raises FY 2025 guidance","bullets":["Revenue $186.7M (+26.1% YoY); gross margin 71.2% (+130 bps).","Net loss $14.2M ($0.44/sh) improved from $20.1M loss ($0.65/sh) in Q2 2024.","Adjusted net loss $10.2M ($0.32/sh) improved from $18.8M loss ($0.61/sh) YoY.","FY 2025 guidance raised: revenue $720M-$730M; adj. EBITDA margin 8.0%-8.5%.","Unrestricted cash $545.5M; partnership with Lucem Health for AI-driven early disease detection."],"urls":{"canonical":"https://secwatch.observer/filing/0001388658-25-000194","json":"https://secwatch.observer/filing/0001388658-25-000194.json","markdown":"https://secwatch.observer/filing/0001388658-25-000194.md","text":"https://secwatch.observer/filing/0001388658-25-000194.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388658/000138865825000194/0001388658-25-000194-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388658/000138865825000194/irtc-20250731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:13:52.701934+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}